Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

BBridgeBio Pharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
B

BridgeBio Pharma, Inc.

$66.50Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $243.68M. Net result −$155.89M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $243.68M. Running result $243.68M. License And Service: $5.8M. Product: $222.44M. Royalty: $15.43M.
  • Cost of revenue: −$15.05M. Running result $228.63M.
  • Gross profit: $228.63M. Running result $228.63M.
  • Research and development: −$149.45M. Running result $79.18M.
  • Selling, general and administrative: −$186.26M. Running result −$107.08M.
  • Restructuring, impairment, and related charges: $0. Running result −$107.08M.
  • Operating income: −$107.08M. Running result −$107.08M.
  • Other expense: −$48.81M. Running result −$155.89M.
  • Pre-tax loss: −$155.89M. Running result −$155.89M.
  • Income tax benefit: $0. Running result −$155.89M.
  • Net loss: −$155.89M. Running result −$155.89M.